For research use only. Not for therapeutic Use.
Abnormal Cannabidiol-d9 (Abn-CBD-d9) is a deuterated analog of abnormal cannabidiol, a cannabinoid that selectively binds to the CB2 receptor with minimal CB1 receptor activity. It is used primarily as a research tool to investigate the effects of cannabinoid receptor modulation and to study the pharmacokinetics and dynamics of cannabinoids. Abn-CBD-d9 serves as a stable isotope-labeled internal standard in mass spectrometry assays, aiding in the accurate quantification of cannabinoids and their metabolites. Its use is crucial for understanding cannabinoid receptor interactions and developing therapeutic agents in pharmaceutical research.
Catalog Number | R028066 |
CAS Number | NA |
Synonyms | 4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol-d9; CAY10429; trans-(-)-4-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol-d9; trans-(-)-4-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol-d9 |
Molecular Formula | C₂₁H₂₁D₉O₂ |
Purity | ≥95% |
Storage | Desiccate at -20C |
IUPAC Name | 4-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-(2,2,3,3,4,4,5,5,5-nonadeuteriopentyl)benzene-1,3-diol |
InChI | InChI=1S/C21H30O2/c1-5-6-7-8-16-12-17(22)13-20(23)21(16)19-11-15(4)9-10-18(19)14(2)3/h11-13,18-19,22-23H,2,5-10H2,1,3-4H3/t18-,19+/m0/s1/i1D3,5D2,6D2,7D2 |
InChIKey | YWEZXUNAYVCODW-BJZWGWCSSA-N |
SMILES | [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CC1=C(C(=CC(=C1)O)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C |